SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 07/18/2025 at 07:00, 11 months 8 days ago

Press Release: Sanofi completes acquisition of Blueprint Medicines
Sanofi completes acquisition of Blueprint Medicines, adding rare immunology disease medicines to its portfolio. The acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis (SM) and elenestinib for SM, enhancing Sanofi's immunology pipeline

Acquisition Sanofi Immunology Blueprint Medicines Ayvakit/Ayvakyt
PRESS RELEASE

published on 07/18/2025 at 07:00, 11 months 8 days ago

Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines
Sanofi finalise l’acquisition de Blueprint Medicines, ajoutant des médicaments sur le marché, un pipeline prometteur et l'expertise en mastocytose systémique. Acquisition bénéfique pour Sanofi, sans impact significatif sur les prévisions financières 2025

Acquisition Médicaments Sanofi Blueprint Medicines Mastocytose Systémique
BRIEF

published on 07/16/2025 at 07:05, 11 months 10 days ago

Sanofi : Désignation "fast track" pour le SAR446597 aux États-Unis

FDA Thérapie Génique Sanofi Dégénérescence Maculaire Fast Track
BRIEF

published on 07/16/2025 at 07:05, 11 months 10 days ago

Sanofi: Fast track designation for SAR446597 in the United States

FDA Gene Therapy Sanofi Macular Degeneration Fast Track
PRESS RELEASE

published on 07/16/2025 at 07:00, 11 months 10 days ago

Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge
Sanofi obtient la désignation 'fast track' pour le traitement innovant de l'atrophie géographique liée à la dégénérescence maculaire. Le SAR446597 vise à inhiber des voies clés du complément pour une meilleure efficacité

Thérapie Génique Sanofi Dégénérescence Maculaire Fast Track Atrophie Géographique
PRESS RELEASE

published on 07/16/2025 at 07:00, 11 months 10 days ago

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
Sanofi's SAR446597 receives fast track designation in the US for geographic atrophy due to age-related macular degeneration, aiming to address unmet medical needs with innovative gene therapy

Gene Therapy Sanofi Fast Track Designation Geographic Atrophy SAR446597
PRESS RELEASE

published on 07/15/2025 at 18:30, 11 months 11 days ago

Sanofi: Disclosure of trading in own shares
PRESS RELEASE

published on 07/15/2025 at 18:30, 11 months 11 days ago

Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE

published on 06/30/2025 at 21:33, 11 months 25 days ago

Sanofi: Disclosure of trading in own shares
PRESS RELEASE

published on 06/30/2025 at 21:33, 11 months 25 days ago

Sanofi : Déclaration des transactions sur actions propres

Published on 06/26/2026 at 15:05, 4 hours 29 minutes ago

Vox Royalty Sells I-80 Gold Offtake Stream
Published on 06/26/2026 at 14:05, 5 hours 29 minutes ago

SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 5 hours 34 minutes ago

Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 6 hours 34 minutes ago

Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 6 hours 49 minutes ago

Northern Dynasty Reports Oral Arguments Held

View all ACCESSWIRE

Published on 06/26/2026 at 19:10, 23 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/26/2026 at 18:04, 1 hour 29 minutes ago

Turkiye Garanti Bankasi A.S.: Bond, subordinated debts, that can be included in the equity calculation debt instrument issuance CMB Application
Published on 06/26/2026 at 18:00, 1 hour 33 minutes ago

PSP Swiss Property has sold the Richtipark in Wallisellen. The EBITDA guidance for the 2026 financial year has been increased.
Published on 06/26/2026 at 18:00, 1 hour 33 minutes ago

VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M
Published on 06/26/2026 at 18:00, 1 hour 33 minutes ago

VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 10,2 M€ entièrement dédiée à soutenir l’expansion commerciale de son offre de produits de santé naturels

View all EQS

Published on 06/26/2026 at 17:45, 1 hour 49 minutes ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 1 hour 49 minutes ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 1 hour 49 minutes ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 4 hours 49 minutes ago

Safran information
Published on 06/26/2026 at 14:44, 4 hours 49 minutes ago

Information Safran

View all LES ECHOS COMFI WIRE

News